Importantly, no cases of severe hypoglycaemia or trial-related deaths have been reported, and most side effects resolved without needing to stop the medication
The two meta-analyses are complementary Pei confirms the overall effect with greater certainty, while Xu provides practical guidance on optimal parameters
This hormone glucagon-like peptide-1 (GLP-1) triggers insulin release, which lowers blood sugar levels by helping usher sugar into cells
10.1007/s00281-004-0176-0 34 GuilliamsM.SvedbergF
Instead, it reflects a mix of genuine patient experiences, social-media storytelling, and misunderstandings about how GLP-1 medications work
The result is reduced appetite, lower blood sugar levels, and meaningful weight loss over time